SCHEMBL4846148

SCHEMBL4846148

COc1cccc(OC)c1-c1ccc(OCCN(C)C)c(C(=O)/C=C/c2ccccc2CN(C)C)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.42
KDM4E B2RXH2 1/20 0.42
BCHE P06276 1/20 0.42
ACHE P22303 1/20 0.42
HRH1 P35367 1/20 0.41
MCHR1 Q99705 1/20 0.40
NR1H4 Q96RI1 3/20 0.40
KEAP1 Q14145 1/20 0.40
NFE2L2 Q16236 1/20 0.40
AR P10275 2/20 0.40
MAOB P27338 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
ALOX5 P09917 1/20 0.39
PTPN1 P18031 1/20 0.39
LMNA P02545 1/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
ATM Q13315 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
KDR P35968 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4852887 1.00 ALDH1A1 (0.42) ALDH1A1KDM4EBCHEACHEHRH1
SCHEMBL4852586 0.91 HTR7 (0.46) ALDH1A1KDM4EBCHEACHEHRH1
SCHEMBL4850209 0.91 HTR7 (0.46) ALDH1A1KDM4EBCHEACHEHRH1
SCHEMBL4846157 0.90 BCHE (0.42) ALDH1A1KDM4EBCHEACHEHRH1
SCHEMBL4846112 0.89 KDM4E (0.39) ALDH1A1KDM4EBCHEACHEHRH1
SCHEMBL4852999 0.89 PTGER1 (0.41) ALDH1A1KDM4EBCHEACHEHRH1
SCHEMBL4854201 0.89 PTGER1 (0.41) ALDH1A1KDM4EBCHEACHEHRH1
SCHEMBL4847346 0.89 KDM4E (0.39) ALDH1A1KDM4EBCHEACHEHRH1
SCHEMBL4849737 0.87 HRH1 (0.39) ALDH1A1KDM4EBCHEACHEHRH1
SCHEMBL4847873 0.87 HRH1 (0.39) ALDH1A1KDM4EBCHEACHEHRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed